Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Respirion Pharmaceuticals Pty Ltd is a Biotechnology Research brand in Perth, Western Australia. Privately held, at respirionpharma.com. It holds one address on record, all in Australia. It employs 5 people, on the record. It lists cystic Fibrosis, non-CF bronchiectasis and inhaled therapeutics among its specialties. One Australian registration (ABN) is a confirmed match. It is listed alongside three similar brands, mostly in Venture Capital and Private Equity Principals.
ABN49623568409
| RESPIRION PHARMACEUTICALS PTY LTD | ABN 49623568409 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Respirion Pharmaceuticals is an early-stage biotechnology company focused on developing new treatments for respiratory disease. The Company is a spinout from the Telethon Kids Institute in Perth where the product development was incubated.
Respirion’s lead product, an inhaled therapy for the life-threatening disease Cystic Fibrosis, has shown promising results in an early clinical study carried out with the Western Australian Department of Health.
Respirion is currently conducting a Phase 1b/2a clinical study in the US and Australia (NCT06016088 and ANZCTR registered) to evaluate the safety and efficacy of its proprietary antibiotic combination for the treatment of lung infections in people with Cystic Fibrosis.
| Countries | 1 |
|---|
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One Western Australia entity on the ABR: RESPIRION PHARMACEUTICALS PTY LTD (ABN 49 623 568 409), high confidence.
5 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only.
None linked to this brand.
Five tags on the brand's own list, among them Cystic Fibrosis, non-CF bronchiectasis and inhaled therapeutics.
4 profiles list Respirion Pharmaceuticals Pty Ltd as a peer — 56th percentile in Biotechnology Research. It lists ten peers of its own. ENA Respiratory lists it back.